-
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Sep 9, 2025, 16:22 PM -
Budget Impact of an Organized Cervical Cancer Screening in High-Risk Populations in France
Sep 9, 2025, 16:22 PM -
Trends in Hospital Treatment of Follicular Lymphoma in Germany
Sep 9, 2025, 16:22 PM -
Multi-Level Factors Influencing Active Surveillance Initiation Among Elderly Medicare Beneficiaries Newly Diagnosed With Low-Risk and Favorable Intermediate-Risk Prostate Cancer: An Active Comparator New User Retrospective Cohort Study in the United...
Sep 9, 2025, 16:22 PM -
Methodological Approach to Assess the Environmental Impact Analysis of Expanding Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) in the Chronic Kidney Disease Patient Pathway: A French Perspective
Sep 9, 2025, 16:22 PM -
Beyond Leave-One-Out: A Ranked Leave-k-Out Method for Detecting Influential Studies
Sep 9, 2025, 16:22 PM -
Microcosting Analysis of Oral, Subcutaneous, and Intravenous Second-line Multiple Sclerosis Treatments Administered at Home or in Hospital
Sep 9, 2025, 16:22 PM -
Evaluate the Statistical Utility After Transformation of a CDISC SDTM Database Into OMOP CDM
Sep 9, 2025, 16:22 PM -
Integrating Stakeholder Willingness-to-Pay Using the Van Westendorp Price Sensitivity Meter Into Cost-Effectiveness Analysis: A Mixed-Methods Pricing Framework
Sep 9, 2025, 16:22 PM -
Health Technology Assessments of Oncology Orphan and Advanced Therapies: The Case for Incorporating Real-World Evidence Patient-Reported Outcomes and Indirect Treatment Comparisons Into Joint Clinical Assessment Submissions
Sep 9, 2025, 16:22 PM -
Clinical and Economic Outcomes of Cannabis-Based Formulations (CBD and CBD/CBG) for Autism Spectrum Disorder (ASD): A HEOR Model Study Analysis
Sep 9, 2025, 16:22 PM -
Impact Of Reimbursement Policy On Medicines Expenditures And Copayment: The Case of Cardiovascular Medicines In Bulgaria
Sep 9, 2025, 16:22 PM -
Lipid-Lowering Prescription Patterns After a Nonfatal Acute Coronary Syndrome: The Impact of Real-World Evidence on Clinical Practice With LATINO-ACS 2.0
Sep 9, 2025, 16:22 PM -
Evaluation of Health-Related Quality of Life (HRQoL) Among Patients Treated With Lifileucel After Progression on Immune Checkpoint Inhibitors (ICIs) and Targeted Therapies: Analyses From the C-144-01 Trial
Sep 9, 2025, 16:22 PM -
Using Propensity Weighting Methods With Real-World Data and Noncontrolled Extension Data From a Clinical Trial to Estimate Long-Term Treatment Effect: An Example in Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Risk of Abdominal Hernia Repair in Patients With Intestinal Stoma in Italy: A Real-World Analysis
Sep 9, 2025, 16:22 PM -
Health Technology Assessment Landscape for Medical Devices in Europe
Sep 9, 2025, 16:22 PM -
Decoding Atorvastatin-Induced Arthritis: A Systems Pharmacology Approach Integrating Pharmacovigilance, Bioinformatics, and Pathway Enrichment
Sep 9, 2025, 16:22 PM -
Parental Vaccine Hesitancy in Children With Comorbidities: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Robotic Surgery: A Budget Analysis in the Italian Healthcare Setting
Sep 9, 2025, 16:22 PM
